Ann-Lii Cheng (Ann-Li Cheng)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Breast Cancer Risk

Histone Deacetylase

Diffuse Large B Cell Lymphoma

Top Venues

British journal of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer prevention research (Philadelphia, Pa.)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas, Akihiko Soyama, Chang-Tsu Yuan, Tse-Ching Chen, Susumu Eguchi, Tomoharu Yoshizumi, Shinji Itoh, Noriaki Nakamura, Hisashi Kosaka, Masaki Kaibori, Takamichi Ishii, Etsuro Hatano, Chikara Ogawa, Atsushi Naganuma, Satoru Kakizaki, Chih-Hsien Cheng, Po-Ting Lin, Yung-Yeh Su, Chien-Huai Chuang, Li-Chun Lu, Chi-Jung Wu, Hung-Wei Wang, Kun-Ming Rau, Chih-Hung Hsu, Shi-Ming Lin, Yi-Hsiang Huang, Sairy Hernandez, Richard S Finn, Masatoshi Kudo, Ann-Lii Cheng
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Bruno Sangro, Peter R Galle, Robin Kate Kelley, Chaiyut Charoentum, Enrico N De Toni, Yurii Ostapenko, Jeong Heo, Ann-Lii Cheng, Andrea Wilson Woods, Charu Gupta, Jayne Abraham, Carrie L McCoy, Nikunj Patel, Alejandra Negro, Arndt Vogel, Ghassan K Abou-Alfa
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Ching-Hung Lin, Muhammad Zahid, Wen-Hung Kuo, Fu-Chang Hu, Ming-Yang Wang, I-Chun Chen, Cheryl L Beseler, Bodhisattwa Mondal, Yen-Shen Lu, Eleanor G Rogan, Ann-Lii Cheng
Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women. Cancer prevention research (Philadelphia, Pa.) 16 (3) (2023)
Chiao-Ling Tsai, Po-Sheng Yang, Feng-Ming Hsu, Ann-Lii Cheng, Wan-Ni Yu, Jason Chia-Hsien Cheng
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity. Journal of clinical and translational hepatology 11 (3) (2023)
Yu-Chieh Tsai, Tzu-Yin Wang, Chia-Lang Hsu, Wei-Chou Lin, Jyun-Yu Chen, Jia-Hua Li, Yeong-Shiau Pu, Ann-Lii Cheng, Jason Chia-Hsien Cheng, Sheng-Fang Su
Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling. British journal of cancer (2023)
Chiao-Ling Tsai, Po-Sheng Yang, Feng-Ming Hsu, Ann-Lii Cheng, Wan-Ni Yu, Jason Chia-Hsien Cheng
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity. Journal of clinical and translational hepatology 11 (3) (2023)
Ching-Hung Lin, Muhammad Zahid, Wen-Hung Kuo, Fu-Chang Hu, Ming-Yang Wang, I-Chun Chen, Cheryl L Beseler, Bodhisattwa Mondal, Yen-Shen Lu, Eleanor G Rogan, Ann-Lii Cheng
Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women. Cancer prevention research (Philadelphia, Pa.) 16 (3) (2023)
Ming Yao, Shu-Lang Liao, Chung-Wu Lin, Cheng-Ping Wang, Wei-Li Ma, Yi-Hsuan Wei, Jyh-Ming Liou, I-Jong Wang, Ann-Lii Cheng, Sung-Hsin Kuo
First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphoma. EJHaem 4 (1) (2022)
Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong, Jen-Chieh Lee, Koping Chang, Chih-Wei Yu, San-Chi Chen, Jhe-Cyuan Guo, Mei-Lu Chen, Meng-Chi Hsu, Ting-Fang Kung, Ann-Lii Cheng, Chueh-Chuan Yen
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Yu-Yun Shao, Pai-Sheng Chen, Liang-In Lin, Bin-Shyun Lee, Andrew Ling, Ann-Lii Cheng, Chiun Hsu, Da-Liang Ou
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma. British journal of cancer 126 (12) (2022)
Ming Yao, Shu-Lang Liao, Chung-Wu Lin, Cheng-Ping Wang, Wei-Li Ma, Yi-Hsuan Wei, Jyh-Ming Liou, I-Jong Wang, Ann-Lii Cheng, Sung-Hsin Kuo
First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphoma. EJHaem 4 (1) (2022)
Kuo-Hsing Chen, Chia-Lang Hsu, Yu-Li Su, Chang-Tsu Yuan, Liang-In Lin, Jia-Huei Tsai, Yi-Hsin Liang, Ann-Lii Cheng, Kun-Huei Yeh
Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer. British journal of cancer (2022)
Gontran Verset, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Adel Kardosh, Vittorina Zagonel, Per Stål, Debashis Sarker, Daniel H Palmer, Arndt Vogel, Julien Edeline, Stephane Cattan, Masatoshi Kudo, Ann-Lii Cheng, Sadahisa Ogasawara, Bruno Daniele, Stephen L Chan, Jennifer J Knox, Shukui Qin, Abby B Siegel, Michael Chisamore, Ken Hatogai, Anran Wang, Richard S Finn, Andrew X Zhu
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Sung-Hsin Kuo, Kun-Huei Yeh, Chung-Wu Lin, Jyh-Ming Liou, Ming-Shiang Wu, Li-Tzong Chen, Ann-Lii Cheng
Current Status of the Spectrum and Therapeutics of Helicobacter pylori -Negative Mucosa-Associated Lymphoid Tissue Lymphoma. Cancers 14 (4) (2022)
Ching-Hung Lin, Muhammad Zahid, Wen-Hung Kuo, Fu-Chang Hu, Ming-Yang Wang, I-Chun Chen, Cheryl L Beseler, Bodhisattwa Mondal, Yen-Shen Lu, Eleanor G Rogan, Ann-Lii Cheng
Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women. Cancer prevention research (Philadelphia, Pa.) (2022)
Baek-Yeol Ryoo, Ann-Lii Cheng, Zhenggang Ren, Tae-You Kim, Hongming Pan, Kun-Ming Rau, Hye Jin Choi, Joong-Won Park, Jee Hyun Kim, Chia Jui Yen, Ho Yeong Lim, Dongli Zhou, Josef Straub, Juergen Scheele, Karin Berghoff, Shukui Qin
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression. British journal of cancer 125 (2) (2021)
Ching-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, Kuan-Ting Kuo, Ko-Yun Lo, Ching-Hsuan Chen, I-Chun Chen, Yen-Shen Lu, Eric Y Chuang, Jean Paul Thiery, Chiun-Sheng Huang, Ann-Lii Cheng
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia. NPJ breast cancer 7 (1) (2021)
Ann-Lii Cheng
Pursuing efficacious systemic therapy for hepatocellular carcinoma. Nature reviews. Gastroenterology & hepatology 18 (2) (2021)
Robin Kate Kelley, Bruno Sangro, William Harris, Masafumi Ikeda, Takuji Okusaka, Yoon-Koo Kang, Shu-Kui Qin, David Wai-Meng Tai, Ho Yeong Lim, Thomas Yau, Wei Peng Yong, Ann-Lii Cheng, Antonio Gasbarrini, Silvia Damian, Jordi Bruix, Mitesh J Borad, Johanna Bendell, Tae-You Kim, Nathan Standifer, Philip He, Mallory Makowsky, Alejandra Negro, Masatoshi Kudo, Ghassan K Abou-Alfa
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Kuo-Hsing Chen, Liang-In Lin, Chang-Tsu Yuan, Li-Hui Tseng, Yu-Liang Chao, Yi-Hsin Liang, Jin-Tung Liang, Been-Ren Lin, Ann-Lii Cheng, Kun-Huei Yeh
Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort. British journal of cancer 125 (1) (2021)
Robin Kate Kelley, Rebecca Miksad, Irfan Cicin, YenHsun Chen, Heinz-Josef Klümpen, Stefano Kim, Zhong-Zhe Lin, Jillian Youkstetter, Saswati Hazra, Suvajit Sen, Ann-Lii Cheng, Anthony B El-Khoueiry, Tim Meyer, Ghassan K Abou-Alfa
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade. British journal of cancer (2021)
Robin Kate Kelley, Patrick Mollon, Jean-Frédéric Blanc, Bruno Daniele, Thomas Yau, Ann-Lii Cheng, Velichka Valcheva, Florence Marteau, Ines Guerra, Ghassan K Abou-Alfa
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma. Advances in therapy 37 (6) (2020)